Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07187479
NA

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Sponsor: Well Cell Global

View on ClinicalTrials.gov

Summary

The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).

Official title: Randomized, Open Label Study to Examine the Outcomes of Physiologic Insulin Resensitization in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-10-14

Completion Date

2026-06

Last Updated

2025-10-20

Healthy Volunteers

No

Interventions

OTHER

Physiologic Insulin Resensitization (PIR)

PIR is a physician-directed treatment that uses an exterior infusion pump to deliver insulin intravenously.

Locations (1)

Arizona Kidney Disease and Hypertension Center

Phoenix, Arizona, United States